Does APREPITANT Cause Peripheral venous disease? 213 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 213 reports of Peripheral venous disease have been filed in association with APREPITANT (CINVANTI). This represents 3.8% of all adverse event reports for APREPITANT.
213
Reports of Peripheral venous disease with APREPITANT
3.8%
of all APREPITANT reports
183
Deaths
211
Hospitalizations
How Dangerous Is Peripheral venous disease From APREPITANT?
Of the 213 reports, 183 (85.9%) resulted in death, 211 (99.1%) required hospitalization, and 209 (98.1%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 213 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which APREPITANT Alternatives Have Lower Peripheral venous disease Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL